Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD).
| Image |  |
|---|---|
| Description | scientific article published in December 2014 |
| Author/s |
author: Josep Antoni Ramos-Quiroga Javier Quintero Cesar A. Soutullo Alberto Fernández-Jaén |
| Publication date | December 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |